1Echt DS, Liebson PR, Peters RW, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the cardiac arrhythmia suppression trial[J]. N Engl J Med, 1991, 324:781 - 788.
2The Cardiac Arrhythmia Suppression Trial Ⅱ Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction [J]. N Engl J Med, 1992, 327:227-233.
3Siebls J, Cappato R, Ruppel R, et al. Preliminary results of cardiac arrest study hambury(CASH) [J]. Am J Cardiol, 1993, 72: 109F -113F.
4Hine LK, Laird N, Hewittp P, et al. Meta- analytic evidence against prophylactic use of lidocaine in acute myocardial infarction [ J ]. Arch Intern Med, 1989, 149:2694 - 2698.
5Doval HC, Nul DR, Grancelli HO, et al. Randomized trial of low - dose amiodarone in severe congestive heart failure[J]. Lancet, 1994, 344:493-499.
6Kreiss Y, Sidi Y, Gur H. Efficacy and safety of intravenous amiodarone in recent onset atrial fibrillation: experience in patients admitted to a general internal medicine department[ J ]. Postgrad Med J, 1999, 75: 278- 281.
9Kreiss Y,Sidi Y,Gur H.Efficacy and safety of intravenous amiodarone in recent onset atrial fibrillation:experience in patients admitted to a general internal medicine department.Postgrad Med J,1999,75:278-281.
10Hunt SA,Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Mangement of Chronic Heart Failure in the adult. Circulation, 2005,112 : 154-235.
